First Houston Capital’s Novartis NVS Stock Holding History

First Houston Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-32,922	Closed	-$2.54M	–	61
2015 Q4	$2.54M	Sell	32,922 -4,799	-13%	-$381K	2.31%	18
2015 Q3	$3.11M	Buy	37,721 +1,228	+3%	+$109K	2.93%	6
2015 Q2	$3.23M	Hold	36,493	–	–	2.88%	7
2015 Q1	$3.23M	Buy	36,493 +2,957	+9%	+$262K	2.82%	7
2014 Q4	$2.78M	Buy	33,536 +1,730	+5%	+$143K	2.47%	12
2014 Q3	$2.68M	Sell	31,806 -6,473	-17%	-$524K	2.51%	11
2014 Q2	$3.1M	Buy	38,279 +670	+2%	+$52.7K	2.97%	3
2014 Q1	$2.87M	Buy	37,609 +725	+2%	+$52.8K	2.8%	2
2013 Q4	$2.66M	Buy	36,884 +502	+1%	+$34.9K	2.61%	10
2013 Q3	$2.5M	Buy	+36,382	New	+$2.41M	2.69%	4

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

First Houston Capital's NVS Position: Q1 2016 in Review

First Houston Capital sold out of Novartis (NVS) in Q1 2016, closing a stake of 32,922 shares — an estimated $2.54M sold.

First Houston Capital first reported a position in NVS in Q3 2013 and held it in 10 quarters. The position peaked at $3.23M in Q2 2015. 875 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

First Houston Capital reported no remaining Novartis position as of Q1 2016 after selling out during the quarter.
First Houston Capital sold 32,922 Novartis shares in Q1 2016, an estimated $2.54M.
First Houston Capital first reported a position in Novartis in Q3 2013 and held it in 10 quarters.
First Houston Capital's Novartis position peaked at $3.23M in Q2 2015.
875 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on First Houston Capital's 13F filing for Q1 2016, filed 16 May 2016.